<DOC>
	<DOC>NCT00414908</DOC>
	<brief_summary>This study assessed the effect of pancrelipase delayed release capsules on fat and nitrogen absorption in subjects with PEI due to Chronic Pancreatitis and Pancreatectomy. There was a run-in with a 5-day of single-blind placebo treatment, followed by a 7-day Double-blind period and a 6-month Open-Label Follow-up.</brief_summary>
	<brief_title>A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis, Chronic</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Pancreatic exocrine insufficiency has to be proven (in medical history) by the following criteria: Direct or indirect pancreatic function test (except stool fat excretion) or Clinical signs of severe steatorrhoea that resolved upon administration of pancreatic supplementation. Total stool fat &gt; 40 g over 4 days (using Van De Kamer method) Proven chronic pancreatitis Females of childbearing potential must agree to continue using a medically acceptable method of birth control Ileus or acute abdomen Any type of malignancy involving the digestive tract in the last 5 years Presence of pseudopancreatic cyst â‰¥ 4 Continued excessive intake of alcohol or drug abuse Known infection with HIV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Chronic Pancreatitis</keyword>
	<keyword>Pancreatectomy</keyword>
	<keyword>Pancreatic Exocrine Insufficiency</keyword>
</DOC>